Balance Sheet

v3.25.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2025
Jun. 30, 2024
Current assets    
Cash $ 2,975,150 $ 661,415
Accounts receivable, net 157,515 606,885
Inventory, net 1,152,870 1,431,556
Due from VitaMedica transition 228,017 212,358
Prepaid expenses and other receivables 350,836 502,188
Current digital assets at fair value 49,913,655 0
Assets available for sale - Building 0 4,005,516
Purchase price receivable - VitaMedica 2,000,000 2,000,000
Purchase price receivable - E-core 0 2,000,000
Total current assets 56,778,043 11,419,918
Property and equipment, net 2,052,573 2,356,556
Intangible assets, net 163,113 239,871
Goodwill 848,854 848,854
Deferred tax asset 5,948,858 5,948,858
Digital assets at fair value, net of current 56,083,525 0
Other assets 192,123 278,435
Right-of-use asset, net 1,739,755 2,418,596
Total other assets 67,028,801 12,091,170
Total assets 123,806,844 23,511,088
Current liabilities    
Accounts payable 1,039,370 481,647
Accrued compensation 3,470,296 1,098,856
Deferred revenue 13,155 235,255
Accrued liabilities 356,064 736,407
Accrued interest 792,449 476,018
Acquisition payable 260,652 413,152
Related party advances, net 0 100,000
Current portion of note payable 560,000 0
Short-term treasury debt 20,000,000 0
Current portion of Cygnet subsidiary notes payable 5,380,910 5,447,565
Note payable on building for sale 0 2,634,538
Current portion of operating lease payable 691,010 1,031,714
Total current liabilities 32,563,906 12,655,152
Operating lease payable, net of current portion 1,145,440 1,732,606
Related party note payable 0 500,000
Note payable 0 557,429
Convertible notes payable 0 1,550,000
Total long-term liabilities 1,145,440 4,340,035
Stockholders' equity    
Preferred stock, $0.00001 par value, 10,000,000 shares authorized, and 150,000 and 25,000 shares issued and outstanding, respectively 2 1
Common stock, $0.00001 par value, 300,000,000 shares authorized, and 38,270,571 and 1,045,429 shares issued and outstanding, respectively 383 11
Additional paid in capital 150,640,935 53,375,502
Accumulated deficit (60,543,822) (46,859,613)
Total stockholders' equity attributable to Upexi, Inc. 90,097,498 6,515,901
Total stockholders' equity 90,097,498 6,515,901
Total liabilities and stockholders' equity $ 123,806,844 $ 23,511,088

Source

PDF HTML
ZIP